Effective Treatments Of Neuroendocrine Colon Cancer
One of the most aggressive and disastrous forms of cancer is neuroendocrine carcinoma of colon. The worst part of this disease is that it is usually detected late into the advanced stages at which time it is more difficult to do anything about it.
As the side effects of neuroendocrine colon cancer take form only in the most advanced stages the rate of survival of the patient diminishes. The polyps or tumors of the colon are always malignant, and mostly detected with distant metastases. In several surveys, the reports have revealed that in a great many cases of neuroendocrine cancer ends in death.
Although the possibilities of neuroendocrine carcinoma in colon are extremely unlikely, if one is affected the health of the patient becomes much worse than those who are suffering from adenocarcinoma.
Research reveals that the final results of this form of cancer stay the same with age, sex or tumor location. Though neuroendocrine colon carcinoma will depend heavily on the tumor’s stage. Normal trends have revealed that people in stage 1 and 2 of cancer will generally not experience neuroendocrine colon cancer. But alternately in the majority of cases when the tumor is in stage 3 or 4, it is a laborious and tough job to treat the neuroendocrine colon carcinoma.
Unfortunately, medical science has very few methods to help patients with this cancer. Among the more popular methods that the doctors often use is immunohistochemical staining methods. This method helps doctors in dealing with the critical nature of the neuroendocrine colon cancer and really helps determine the best medication and treatment for it. Immunohistochemical staining methods is specifically used for neuroendocrine markers. Involved in that, is the staining of said tumor with an antibody called A-80 which helps in identifying the quantum of neuroendocrine differentiation and the extent of damage on the health of the patient.
Neuroendocrine colon carcinoma is difficult to treat and in a case study in which several patients stuffered from this disease were extensively examined it was observed that the overall survival rate for this disease was only about seven months. While in a predominant stage, the rates were as less as five months. Most cases were originally seen as carcinoids but later they developed in to neuroendocrine colon carcinoma. Neuroendocrine colon cancer has a poor prognosis and surgery may not be a successful treatment so, even surgery does not even cure the patient. Therefore it becomes necessary to detect this disease as soon as possible and provide proper medication for it.
